TABLE 3.
Antibiotic | No. of strains
|
|||||||
---|---|---|---|---|---|---|---|---|
S. mitis (n = 25) | All non-S. mitis (n = 25) | Streptococcus sp. (n = 11) | S. parasanguis (n = 5) | S. salivarius, S. vestibularis (n = 3) | S. anginosus (n= 3) | S. gordonii, S. sanguis, S. sobrinus (n = 3) | Resistance comparisonb | |
Vancomycin | S25 | S25 | S11 | S5 | S3 | S3 | S3 | NS |
Linezolid | S25 | S23/I2 | S11 | S4/I1 | S3 | S2/I1 | S3 | NS |
Quin-dalfo | S24/I1 | S23/I2 | S11 | S4/I1 | S3 | S2/I1 | S3 | NS |
Ceftriaxone | S18/I4/R3 | S23/I1/R1 | S9/I1/R1 | S5 | S3 | S3 | S3 | NS |
TMP-SMZ | S14/I3/R8 | S20/I1/R4 | S9/I1/R1 | S4/R1 | S3 | S2/R1 | S2/R1 | NS |
Tetracycline | S15/I1/R9 | S15/I2/R8 | S6/I1/R4 | S1/I1/R3 | S3 | S2/R1 | S3 | NS |
Azithromycin | S9/I3/R13 | S16/R9 | S8/R3 | R5 | S2/R1 | S3 | S3 | NS |
Penicillin | S11/I7/R7 | S14/I11 | S7/I4 | I5 | S1/I2 | S3 | S3 | P = 0.004 |
Gatifloxacin | S9/I2/R14 | S16/I1/R8 | S5/R6 | S3/I1/R1 | S2/R1 | S3 | S3 | NSc |
Levofloxacin | S8/I1/R16 | S16/R9 | S5/R6 | S3/R2 | S2/R1 | S3 | S3 | P = 0.048 |
Ciprofloxacin | S4/I2/R19 | S9/I3/R13 | I2/R9 | S2/I1/R2 | S2/R1 | S3 | S2/R1 | P = 0.077 |
R to ≥3 classes | 14 | 3 | 2 | 1 | P = 0.001 |
Abbreviations: S, susceptible; I, intermediate; R, resistant; NS, not significant; Quin-dalfo, quinupristin-dalfopristin; TMP-SMZ, trimethoprim-sulfamethoxazole.
S. mitis strains versus all non-S. mitis strains.
P = 0.048 when susceptible strains were compared (9/25 versus 16/25).